New cancer clinical trial: IRX-2, Cyclophosphamide, and Nivolumab in Treating Participants With Recurrent or Metastatic and Refractory Liver Cancer

Published on: August 31, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share